Compare GH & GVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GH | GVA |
|---|---|---|
| Founded | 2011 | 1922 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 4.5B |
| IPO Year | 2018 | 1990 |
| Metric | GH | GVA |
|---|---|---|
| Price | $101.88 | $107.99 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 21 | 3 |
| Target Price | $79.19 | ★ $105.00 |
| AVG Volume (30 Days) | ★ 2.4M | 673.0K |
| Earning Date | 10-29-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 0.48% |
| EPS Growth | N/A | ★ 68.53 |
| EPS | N/A | ★ 3.67 |
| Revenue | $902,569,000.00 | ★ $4,236,312,000.00 |
| Revenue This Year | $34.72 | $11.29 |
| Revenue Next Year | $26.46 | $10.61 |
| P/E Ratio | ★ N/A | $29.47 |
| Revenue Growth | ★ 30.38 | 6.87 |
| 52 Week Low | $29.91 | $69.08 |
| 52 Week High | $112.43 | $112.16 |
| Indicator | GH | GVA |
|---|---|---|
| Relative Strength Index (RSI) | 56.90 | 64.09 |
| Support Level | $103.36 | $105.38 |
| Resistance Level | $109.59 | $107.92 |
| Average True Range (ATR) | 5.54 | 2.47 |
| MACD | -1.11 | 0.60 |
| Stochastic Oscillator | 42.83 | 84.45 |
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Granite Construction Inc engages in the construction and development of various infrastructure projects on behalf of public and private clients in the United States. It focuses on heavy civil infrastructure projects, including roads, highways, transit facilities, airports, bridges, and other infrastructure projects. In addition, the company performs site preparation and infrastructure services for residential development, energy development, and other facilities. The majority of revenue is derived from the company's Construction operating segment, with the remainder derived from its Materials segment.